Pharmaceutical companiesPharmaceutical companies have little incentive to test when they cannot patent the drug they are underwriting the testing for. I think this marketplace is going to remain the domain of focused cannbis companies that understand the weed business but are knowledgable about pharma and have diversified into other holdings....just like Australis,so I’m in.